Identification and Treatment of Men With BPH in the Primary Care Setting
NCT00211640 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1100
Last updated 2005-09-21
Summary
Male patients between the ages of 18 to 100 years of age who entered the Mid Michigan Health Center were administered a patient demographic questionnaire, a Lower Urinary Tract Symptom (LUTS) questionnaire, and the Men's Sexual Health Questionnaire (MSHQ) without exception. The purpose of this study was to better identify symptoms of benign prostatic hyperplasia (BPH) with the intent to prescribe better and more helpful treatment options for patients demonstrating these symptoms.
Conditions
- No Conditions for This Study. All Male Patients 18 Years of Age or Older Were Administered the LUTS, MSHQ, and Patient Demographics Questionnaire
Sponsors & Collaborators
-
Mid Michigan Health Centers
lead OTHER
Principal Investigators
-
Matt T Rosenberg, M.D. · Mid Michigan HC Partner
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Database for the Assessment of Efficacy and Safety of BPH Treatment
NCT03521648 ·Status: RECRUITING
-
Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.
NCT05508165 ·Status: RECRUITING ·Phase: NA
-
The Influence of Benign Prostatic Hyperplasia on Bladder Function
NCT03098147 ·Status: UNKNOWN
-
MCS in the Treatment of Lower Urinary Tract Symptoms
NCT01002417 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
NCT01939184 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH
NCT05757687 ·Status: RECRUITING ·Phase: NA
-
The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects
NCT00710749 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With BPH and LUTS
NCT01589263 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia
NCT02245529 ·Status: COMPLETED
-
Prostate Artery Embolization: Single Center Experience
NCT04766268 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients
NCT02244229 ·Status: COMPLETED ·Phase: PHASE4
-
Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c)
NCT01002222 ·Status: COMPLETED ·Phase: PHASE3
-
Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
NCT03669692 ·Status: WITHDRAWN ·Phase: NA
-
Study of Median Lobe Prostatic UroLift Procedure
NCT02625545 ·Status: COMPLETED ·Phase: NA
-
Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study
NCT03228485 ·Status: COMPLETED
-
Prevalence of Bacteriuria, Antibiotic Susceptibility, and Treatment Response in Symptomatic Benign Prostatic Hyperplasia
NCT06520267 ·Status: COMPLETED
-
Outcomes of MIST for BPH: A Single-Institution Prospective Study
NCT06275256 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
MCS in Treating Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia
NCT00501371 ·Status: TERMINATED ·Phase: PHASE3
-
BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH)
NCT01520441 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH
NCT04627701 ·Status: RECRUITING ·Phase: NA
-
RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up
NCT05784558 ·Status: WITHDRAWN
-
Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH
NCT04987892 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy of Prostatic Artery Embolization (PAE) in Patients With Severe Benign Prostatic Hyperplasia (BPH)
NCT02167919 ·Status: COMPLETED ·Phase: NA
-
Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
NCT01846793 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia
NCT00237536 ·Status: TERMINATED ·Phase: PHASE2